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PURPOSE: To investigate dosimetric and clinical parameters that will predict radiation-
induced acute nausea and vomiting in Intensity Modulated Radiation Therapy (IMRT) 
alone for undifferentiated carcinoma of the nasopharynx (NPC) MATERIALS: Thirty 
three consecutive patients with newly diagnosed NPC were treated with IMRT alone in 
this combined retrospective and prospective cohort. No chemotherapeutic agents were 
given as they either have stage I to IIB (AJCC 2002 classification) diseases or they were 
medically unfit for chemotherapy. Patients receiving any form of chemotherapy were 
excluded as cisplatin, the standard chemotherapeutic agent used in radical treatment of 
NPC is highly emetogenic which may make analysis difficult. Pre-radiotherapy magnetic 
resonance imaging (MRI) images of the head and neck region in the treatment position 
were co-registered with the planning computed tomography (CT) images of these patients 
immobilized in standard thermoplastic casts. The area postrema (AP) as well as the left 
and right vestibules (VB-L and VB-R respectively), which were well-recognized as the 
vomiting centres in the brain were contoured with the aid of the co-registered MRI 
images. A structure combining both VB-L and VB-R named as VB-T was also generated. 
They were all labeled as organs-at-risk (OAR). An additional 3mm three-dimensional 
margin to these structures was created and labeled as AP+3mm, VB-L+3mm, VB-
R+3mm and VB-T+3mm respectively to account for the physiological body motion and 
the setup error. No weightings were given to these structures during optimization in 
computer treatment planning. Dosimetric parameters including volumes of all OARs, 
minimum, mean, maximum, median, V30, V35, V40, V45, V50, V55, V60, V65, D05 
and D01 were recorded from dose-volume histograms (DVH). Prospective monitoring of 
acute nausea and vomiting during IMRT was graded based on Common Toxicity Criteria 
Adverse Events Version 3.0 (CTCAE). A retrospective analysis of these dosimetric 
parameters together with other clinical parameters for their association with acute nausea 
and vomiting was performed using univariate and multivariate logistic regression. 
RESULTS: 5 (15.2%) patients reported grade 1 and another 4 (12.1%) patients reported 
grade 2 nausea respectively. Also 1 (3.0%) patient complained grade 1 and 3 patients 
(9.1%) experienced grade 2 vomiting. No patients developed protracted nausea and 
vomiting after completion of IMRT. For radiation-induced acute nausea, V40 of VB-L 
(p=0.041), V35 of VB-L+3mm (p=0.050), V40 of VB-L +3mm (p=0.049), volume of 
VB-R (p=0.034) and V40 of VB-T (p=0.046) were found to be predictors on univariate 
analysis. On multivariate analysis, volume of VB-R (p=0.049) was the only predictor 
though V40 of VB-L (p=0.076), V40 of VB-L+3mm (p=0.071) and V40 of VBT 
(p=0.081) reached marginal significance. No parameters were predictors of radiation-
induced acute vomiting since the number of patients and event outcomes were too small 
for analysis. No clinical parameters including sex, age, smoking history, overall stage, T-
stage, N-stage were found to be predictors of both acute nausea and vomiting. 
CONCLUSIONS: Both vestibules deserve to be considered as essential OARs in an 
attempt to reduce radiation-induced acute nausea and vomiting. Weighting should be 
offered to these structures during optimization in the treatment planning of IMRT. 
Further patient accural is noteworthy to consolidate our preliminary findings. 
